Pancreatic Cancer Research

ResearcherNankai UniversityNo recent work listed

Ruikun Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-1175-7868; OpenAlex author ID A5100717073. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment. Co-author DOI 10.7150/thno.83495↗
  2. CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell… Co-author DOI 10.1136/jitc-2021-003809↗
  3. Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.ymthe.2020.10.027↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Youjia Cao · 3 shared papers, 2021–2023 · strength 0.39
  2. Hongkai Zhang · 3 shared papers, 2021–2023 · strength 0.39
  3. Shiyu Liu · 2 shared papers, 2022–2023 · strength 0.27
  4. Cuizhu Zhang · 2 shared papers, 2021–2022 · strength 0.25
  5. Yuan Wang · 1 shared paper, 2023 · strength 0.13
  6. Wenrui Gao · 1 shared paper, 2023 · strength 0.13
  7. Mingjuan Du · 1 shared paper, 2023 · strength 0.13
  8. Wei Wang · 1 shared paper, 2023 · strength 0.13
  9. Liming Zhang · 1 shared paper, 2021 · strength 0.12
  10. Nianchao Zhang · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.